Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32305
CAS Number:
132732-60-6, 160549-11-1
3,4,6-Tri- O -bencil-2-desoxi-D-glucopiranosa
Purity:
≥ 95 % (HPLC)
Documents
$106.96 /100 mg
Tamaño
Request Bulk Quote
Product Information

Conservar alejado de agentes oxidantes y fuentes de ignición. Manipular y almacenar en atmósfera inerte.

CAS Number
132732-60-6, 160549-11-1
Purity
≥ 95 % (HPLC)
Molecular Formula
C27H30O5
Molecular Weight
434.52
MDL Number
MFCD06797170
PubChem ID
12903125
Melting Point
104 - 108? C
Appearance
Polvo cristalino de color blanco a beige.
Optical Rotation
[a] D20
Conditions
Conservar entre 2 y 8 °C.
General Information
CAS Number
132732-60-6, 160549-11-1
Purity
≥ 95 % (HPLC)
Molecular Formula
C27H30O5
Molecular Weight
434.52
MDL Number
MFCD06797170
PubChem ID
12903125
Melting Point
104 - 108? C
Appearance
Polvo cristalino de color blanco a beige.
Optical Rotation
[a] D20
Conditions
Conservar entre 2 y 8 °C.
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

3,4,6-Tri-O-benzyl-2-deoxy-D-glucopyranose is widely utilized in research focused on:

  • Synthesis of Glycosides: This compound serves as a key intermediate in the synthesis of various glycosides, which are important in pharmaceuticals and biochemistry.
  • Drug Development: Its unique structure allows for the modification of drug molecules, enhancing their efficacy and bioavailability in therapeutic applications.
  • Bioconjugation: It is used in bioconjugation processes, helping to attach biomolecules to surfaces or other molecules, which is crucial in developing targeted drug delivery systems.
  • Research in Carbohydrate Chemistry: This compound is a valuable tool for researchers studying carbohydrate structures and their interactions, aiding in the understanding of biological processes.
  • Production of Antibody-Drug Conjugates: Its properties make it suitable for creating antibody-drug conjugates, which are innovative treatments for various cancers, improving treatment specificity and reducing side effects.

Citas